Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Benefitting from Embedded Quality for End-to-End Success
Servier
Apr 6, 2017
PTV-M01-17-NS-010
CDMO
Supply Chain
PA TV (video)
Gwenael Servant, Managing Director, Servier CDMO
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
Related Content
Capacity
Is the Bioreactor Arms Race Over?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-01
Sep 1, 2026
Biologics
Commercial Thinking Begins in Clinical Phases
Mathias Kahl
IDT Biologika
PAO-08-26-CL-02
Sep 1, 2026
TPDs
Low Dose, High Impact: Microdosing, Content Uniformity, and Precision Control in TPDs
David O’Connell
PCI Pharma Services
PAO-08-26-CL-04
Aug 31, 2026
Lipase Risk
An Integrated Analytical Approach to Lipase Risk Management in Biologics Development
Kyeyeon Hur, Ph.D.; Jimin Kim, Ph.D.; Minjeong Lee; Soojeong Oh; Woojung Jun
Samsung Biologics
PAO-08-26-CL-10
Aug 31, 2026
New Brand
QPharma Builds on a Trusted Legacy to Shape the Future of Complex Drug Delivery
QPharma
PR-08-26-04
Aug 31, 2026
Fun
Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion
Samsung Biologics
PR-08-26-03
Aug 31, 2026
Partner Selection
How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?
Pharma's Almanac
PAO-08-26-RT-01
Aug 28, 2026
Chinese Biopharma
Pharmaceutical Innovation in China Takes Center Stage
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-17
Aug 25, 2026
Potency Assurance
Why Potency Cannot Be Reduced to a Release Assay in Active Immunotherapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-26-PA-16
Aug 24, 2026
Preparedness
Preparing Manufacturing Networks for the Next Pandemic
Pharma's Almanac
PAO-08-26-PA-14
Aug 20, 2026
Supply Chain
Supply Chain Resilience in 2026: Any Progress?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-15
Aug 19, 2026
New Facilities
SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus
SK pharmteco
PR-08-26-02
Aug 18, 2026
Previous slide
Next slide
